Home/Filings/4/0001437749-21-016509
4//SEC Filing

Francois Eric 4

Accession 0001437749-21-016509

CIK 0001053691other

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 9:41 PM ET

Size

18.4 KB

Accession

0001437749-21-016509

Insider Transaction Report

Form 4
Period: 2021-07-01
Transactions
  • Award

    Restricted Stock Unit

    2021-07-01+69,40069,400 total
    Common Stock (69,400 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-07-01+83,30083,300 total
    Exercise: $0.72Exp: 2031-07-01Common Stock (83,300 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-07-01+83,30083,300 total
    Exercise: $0.72Exp: 2031-07-01Common Stock (83,300 underlying)
Footnotes (4)
  • [F1]The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021.
  • [F2]The shares underlying the options will vest in 18 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over an 18-month period beginning July 1, 2021.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F4]The shares underlying the restricted stock units will vest in 6 equal (or as nearly equal as possible) tri-monthly installments on the last calendar day of every third month over an 18-month period beginning on January 1, 2023.

Issuer

Diffusion Pharmaceuticals Inc.

CIK 0001053691

Entity typeother

Related Parties

1
  • filerCIK 0001656125

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 9:41 PM ET
Size
18.4 KB